APAlejandro Pando

Alejandro Pando

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alejandro Pando has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • James K. Liu

    Department of Neurosurgery, Cooperman Barnabas Medical Center, RWJ Barnabas Health, Livingston, NJ, USA

    4 shared publications
  • Caryn J. Ha

    Department of Neurosurgery (Y.L.-C., A. Sabra, C.J.H., N.N., A. Sahoo, T.H., N.E.S., A. Singla, P.K., F.O.O.), Rutgers the State University of New Jersey, Newark

    3 shared publications
  • Hai Sun

    Department of Neurological Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

    2 shared publications
  • Jean Anderson Eloy

    Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA

    2 shared publications
  • Yaxel Levin-Carrion

    Department of Neurological Surgery, Rutgers New Jersey Medical School, 185 S Orange Ave, Newark, NJ, 07103, USA

    2 shared publications
  • Yaxel Levin-Carrion

    Rutgers New Jersey Medical School, Newark, USA

    2 shared publications

Latest Publications

  • Open Access

    Survival and prognostic factors of anaplastic hemangiopericytoma/solitary fibrous tumor grade III

    by Alejandro Pando, Aman M. Patel, Daniel J. Valdivia, Cynthia T. Daut, Yaxel Levin-Carrion, Vraj Shah, Amar Desai, Prayag Patel, Jean Anderson Eloy, James K. Liu, et al.

    Background: Anaplastic Hemangiopericytoma (AHPC), now known as Solitary Fibrous Tumor (SFT) Grade III, is a rare biologically aggressive neoplasm with a high rate of recurrence. Owing to its rarity, the existing literature is limited regarding its clinical characteristics, prognostic factors, management, and treatment strategies. In this study, we evaluate the association between patient demographics, clinical variables, and treatment modalities with overall survival in patients with intracranial AHPC/SFT Grade III. Methods: The National Cancer Database (NCDB) was queried for the clinical and care parameters of patients ≥ 18-years-old diagnosed with AHPC between 2004 and 2017. Multivariable Cox proportional hazards model was implemented to determine factors associated with overall survival. Results: 427 patients were identified with a mean age of 52.6 ± 0.7 years. Most patients were between 40–70 years old (67.0%) with patients ≤ 40-years-old making up 21.3% and those ≥ 70-years-old making up only 11.7%. Overall median survival was 10.8 years. When stratified based on age, those ≤ 40-years-old had increased mean survival compared to those ≥ 70-years-old (10.8 vs. 6.6 years; p < 0.001). On multivariable analysis, increasing age ( p = 0.006) and the receipt of chemotherapy was associated with decreased overall survival. In contrast, private insurance and managed care ( p = 0.021), treatment with surgery alone ( p = 0.003), or combined surgery and radiation therapy ( p = 0.001) were independently associated with significantly improved overall survival. Conclusion: In this NCDB cohort of intracranial grade III SFT/HPC, improved overall survival was associated with younger age, private insurance status, and treatment with surgery alone or surgery combined with radiation therapy. Chemotherapy was not associated with a survival benefit. Interpretation of treatment effects should be cautious, given the potential for selection bias in chemotherapy utilization and the risk of immortal time bias analyses of radiotherapy. Continued advances in therapeutic strategies are needed to further improve survival in this rare and clinically devastating disease.

  • Open Access

    Extracellular vesicles in spine tumors: biological roles, immune modulation, and therapeutic implications

    by Alejandro Pando, Yaxel Levin-Carrion, Gabriella Pelofsky, Jayant Bhasin, Thaddeus Harbaugh, Arman Sawhney, Hai Sun

    Spinal tumors, whether primary or metastatic, represent a diverse and clinically challenging group of CNS neoplasms. Recent advances in tumor biology have highlighted extracellular vesicles (EVs) as central to tumor biology. This narrative review aimed to examine the emerging role of extracellular vesicles in the pathogenesis, diagnosis, and treatment of spinal tumors and metastases, synthesizing data from preclinical and clinical studies. Tumor-derived EVs in spinal tumors modulate oncogenic signaling, angiogenesis, and immune evasion. In meningiomas and schwannomas, EVs influence tumor behavior and offer potential biomarkers such as miR-497 and e-hTERT. In astrocytomas, circulating EV-circRNAs may enable noninvasive diagnosis and monitoring. In neurofibromas, fibroblast-derived EVs enhance tumor proliferation via VEGF delivery. Metastatic spinal tumors exploit EVs to condition pre-metastatic niches and promote osteolytic or osteoblastic changes via specific miRNAs and proteins. Immune modulation by EVs, including M2 macrophage polarization and T-cell suppression further supports tumor growth. Therapeutically, EVs are being explored as vehicles for targeted drug delivery and as targets themselves via inhibition of EV biogenesis or uptake.


  • Open Access

    Risk Factors for Lower Extremity Deep Vein Thrombosis by Spinal Cord Injury Level: A Population-Based Analysis

    by Alejandro Pando, Caryn J Ha, Yaxel Levin-Carrion, Ahmed Sabra, Max Ward, Daniel M Schneider, Drew Thibault, Sheng-Fu Larry Lo, Daniel M Sciubba

    Study Design: A retrospective database analysis. Objective: To determine the incidence of lower extremity deep vein thrombosis (DVT) and identify risk factors associated with DVT development in patients with spinal cord injury (SCI), stratified by level of injury. Methods: The National Inpatient Sample from 2016 to 2021 was used to identify adult inpatients with SCI who developed DVT within the same admission and to categorize them by anatomical injury level. Multivariable logistic regression was used to assess independent risk factors by SCI level. Results: Among 59,498 SCI patients, the overall DVT incidence was 2.8%. The DVT rate was lowest in cervical SCI (2.6%) and highest in thoracic SCI (3.2%). Pulmonary embolism was a strong independent risk factor for DVT across all SCI levels ([Cervical] OR: 12.82, CI: 10.46-15.63, [Thoracic] OR: 11.82, CI: 9.13-15.20, [Lumbar] OR: 11.38, CI: 6.74-18.74). For cervical SCI, risk factors included coagulopathies (OR: 1.90, CI: 1.54-2.32), older age (OR: 1.01, CI: 1.01-1.02), complete (OR: 1.84, CI: 1.43-2.35) or incomplete cervical lesion (OR: 1.38, CI: 1.17-1.63), cervical (OR: 1.34, CI: 1.16-1.54) or lumbar fracture (OR: 1.58, CI: 1.17-2.11), and upper extremity DVT (OR: 3.58, CI: 2.53-4.97). For thoracic SCI, risk factors included thoracic fracture (OR: 1.46, CI: 1.20-1.77), upper extremity DVT (OR: 3.82, CI: 2.18-6.36), and fluid/electrolyte disorder (OR: 1.35, CI: 1.13-1.62). For lumbar SCI, fluid/electrolyte disorder (OR: 1.92, CI: 1.38-2.66) was an independent predictor. Conclusion: DVT incidence and risk factors vary by SCI level. Identifying these factors is critical for stratifying care and developing tailored prophylactic strategies that prevent adverse events and optimize patient outcomes.


  • Takotsubo Cardiomyopathy After Subarachnoid Hemorrhage: Who Is At Risk?

    by Alejandro Pando, Roger Cheng, Caryn J. Ha, Gaurav Gupta, Arevik Abramyan, Sourav Mukherjee, Jeffrey Pradeep Raj, James K. Liu, Hai Sun, Kiwon Lee

    Introduction: Takotsubo Cardiomyopathy (TCM) is a rare but well recognized complication of subarachnoid hemorrhage associated with increased morbidity and poor clinical outcomes. There is a scarcity of literature describing the prevalence and risk factors associated with this complication. The aim of this study was to identify patients who are at risk of developing TCM in non-traumatic subarachnoid hemorrhage. Methods: The 2016 to 2021 National Inpatient Sample (NIS) was used to identify adult inpatients with a primary diagnosis of non-traumatic subarachnoid hemorrhage. Univariate and multivariable analyses adjusting for patient demographics, comorbidity status, and hemorrhage etiology were used to characterize statistical associations with disease-related complications. Patients with TCM were further divided into those with “good” or “poor” functional outcomes and compared. Results: A total of 42 141 patients were identified as having a subarachnoid hemorrhage from 2016 to 2021. Of these patients 486 patients (1.2%) were found to have TCM. TCM was associated with increased length of stay (19.15 ± 17.8 days vs 11.72 ± 14.4, P < .001), increased total costs ($451 502.59 ± 443 777.9 vs $242 327.92 ± 338 862.3, P < .001), increased number of days from admission to first procedure (1.74 ± 4.5 vs 1.94 ± 5.0, P < .001), and increased mortality (31.7% vs 22.8%, P < .001). After controlling for confounding factors, independent risk factors for TCM in patients with non-traumatic subarachnoid hemorrhage included: Female (Odds Ratio [OR]: 3.11, 95% Confidence Interval [CI]: 2.50-3.89, P < .001), Congestive Heart Failure (OR:4.60, CI:3.70-5.71, P < .001), and Fluid and Electrolyte Disorders (OR: 2.52, CI: 2.05-3.11, P < .001). Patients with good functional outcomes were found to have younger age (54.85 years ± 14.0 vs 58.14 ± 14.7, P < .001), decreased length of stay (17.11 ± 16.9 vs 19.83 ± 18.1, P < .001), decreased total charge ($370 245.94 ± 517 702.8 vs $477 366.55 ± 417 122.4, P < .001), and decreased mortality ( P < .001) compared to those with poor functional outcomes. Conclusion: TCM after subarachnoid hemorrhage is associated with increased mortality, length of stay, total cost, number of procedures in patients, and number of days to first procedure. Neurosurgeons and Neurocritical care medical professionals should be aware of the comorbidities and factors associated with increased TCM after subarachnoid hemorrhage in order to improve patient outcomes.


    • 17 September 2024

    Managing Cerebrospinal Fluid (CSF) Leak after Lumbar Spinal Fusion: When Conservative Treatment is not the Answer?

    by Pando Alejandro, Hanna Gabriel, Kamil Robert, Raj Jeffrey, Bryk Eli, K Liu James, Gillick John, Goldstein Ira

    CSF leaks are a known complication of lumbar fusion surgery. There is a scarcity of literature describing the management of this complication. The aim of this study was to identify patients who are at risk of requiring further intervention for managing CSF leaks. The Nationwide Inpatient Sample (NIS) database was used to identify patients who had lumbar fusion in the United States from 2002 to 2014. Inpatient outcomes including the incidence and risk factors for requiring an intervention were calculated. Secondary outcomes including average length of stay (LOS), mean cost, and mortality rates were calculated. All statistical analyses were conducted based on multivariate regression models using the SPSS software. A total of 11,636 patients with post-operative CSF leak after elective lumbar fusion were identified in the NIS database from 2002 to 2014. Of these patients, 79.9% (9,294/11,636) required an advanced intervention including epidural blood patch, simple repair, or operative management. There was an increase of 13% per year in the use of an intervention in managing CSF leaks. After controlling for several confounding factors, independent risk factors for requiring an intervention included: older age (OR: 1.01; 95% CI: 1.005-1.013; p<0.0001), lateral approach (OR: 1.52; 95% CI: 1.26-1.81; p<0.0001) and posterior approach (OR: 1.60; 95% CI: 1.34-1.91; p<0.0001) compared to anterior approach. Nonsurgical treatment was associated with increased length of stay (5.93±4.61 vs. 5.25±3.63;p0.05). Spine surgeons should be aware of certain patient and procedure-specific characteristics that increase the risk of requiring an intervention for CSF leak management after lumbar fusion to improve patient outcomes.


  • Robotic assistance in lumbar fusion surgery: trends and patterns from 2016–2019

    by Alejandro Pando, Gabriel Hanna, Ira Goldstein

    Purpose Robotic-assisted spine surgery is an emerging field that is growing in utilization. Intraoperative robotic surgical units cost upwards of $600,000 for medical facilities to purchase. Despite significant cost barriers, these devices are highly marketable for hospitals and physicians. Methods The Nationwide Inpatient Sample database from 2016 to 2019 was reviewed. Inclusion criteria were patients over 18 years of age who underwent elective lumbar spinal fusion. Trends of robotic-assisted lumbar fusion were examined over time, as well as stratified based on patient and surgical characteristics. Results A total of 176,377 patients met the inclusion criteria. The overall rate of robotic-assisted lumbar fusion was 1.2% (2,131/174,246). Patients with private insurance were more likely to receive robotic-assisted lumbar fusion (40.3% vs. 37.5%; p < 0.05). Stratifying by race, whites were more likely to receive robotic-assisted lumbar fusion (84.1% vs. 79.5%; p < 0.05). Patients who underwent robotic-assisted lumbar fusion were significantly more likely to have a diagnosis of spondylolisthesis compared to those that underwent non-robotic-assisted lumbar fusion (25.9% vs. 22.0%; p < 0.05). Patients with lumbar fusion done via the anterior approach were more likely to have robotic-assisted surgery compared to other approaches (25.2% vs. 21.3; p < 0.05). Overall, there was a steady increase in its use over time, with patients who underwent lumbar fusion procedures four times more likely to receive robotic assistance in 2019 compared to 2016 (OR: 4.0; 95% CI: 3.5–4.6; p < 0.0001). Robotic-assisted lumbar fusion was associated with higher inpatient costs ($170,036.40 vs. $139,026.10; p < 0.0001) despite having equivalent length of stay (3.31 ± 2.6 vs.3.37 ± 2.6; p = 0.06). Conclusion Robotic-assisted lumbar fusion is on the rise. Patients who had private insurance, were diagnosed with spondylolisthesis, and who had lumbar fusion via the anterior approach were more likely to undergo lumbar fusion using robotic assistance.


  • Analysis of Neurosurgery Influencers on Instagram: Trends and Patterns of the Neurosurgeon's Social Media Footprint

    by Alejandro Pando, Christopher E. Talbot, Daniel J. Valdivia, James K. Liu